Morgan Stanley raises AbbVie price target to $310
Morgan Stanley raised its AbbVie price target to $310 from $296, maintaining an Overweight rating, per Benzinga.
Story updates
02:33:09 PM UTC
SquawkNews
AbbVie Price Target Raised to $310.00/Share From $296.00 by Morgan Stanley